These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9360404)

  • 21. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
    J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
    Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
    Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system.
    Lavigne C; Thierry AR
    Biochem Biophys Res Commun; 1997 Aug; 237(3):566-71. PubMed ID: 9299405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
    Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
    Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
    Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.
    Tao M; Miyano-Kurosaki N; Takai K; Takaku H
    FEBS Lett; 1999 Jul; 454(3):312-6. PubMed ID: 10431829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system.
    Zhang T; Zhao PS; Zhang W; Liang M; Gao YW; Yang ST; Wang TC; Qin C; Wang CY; Xia XZ
    Vaccine; 2011 Feb; 29(8):1558-64. PubMed ID: 21215341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo.
    Arora V; Iversen PL
    Drug Metab Dispos; 2000 Feb; 28(2):131-8. PubMed ID: 10640509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides.
    Ponnappa BC; Israel Y; Aini M; Zhou F; Russ R; Cao QN; Hu Y; Rubin R
    Biochem Pharmacol; 2005 Feb; 69(4):569-77. PubMed ID: 15670576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligonucleotides derived from the packaging signal at the 5' end of the viral PB2 segment specifically inhibit influenza virus in vitro.
    Giannecchini S; Clausi V; Nosi D; Azzi A
    Arch Virol; 2009; 154(5):821-32. PubMed ID: 19370391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hepatitis B virus in vitro by antisense oligonucleotides.
    Yao ZQ; Zhou YX; Guo J; Feng ZH; Feng XM; Chen CX; Jiao JZ; Wang SQ
    Acta Virol; 1996 Feb; 40(1):35-9. PubMed ID: 8886096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of modified 5'-capped short RNA fragments on influenza virus RNA polymerase gene expression.
    Tado M; Abe T; Hatta T; Ishikawa M; Nakada S; Yokota T; Takaku H
    Antivir Chem Chemother; 2001 Nov; 12(6):353-8. PubMed ID: 12018680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.
    Lavigne C; Yelle J; Sauvé G; Thierry AG
    AAPS PharmSci; 2001; 3(1):E7. PubMed ID: 11741258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.